| Primary |
| Glioblastoma Multiforme |
55.6% |
| Glioma |
22.2% |
| Antidepressant Therapy |
11.1% |
| Antifungal Prophylaxis |
11.1% |
|
| Nephrogenic Diabetes Insipidus |
25.0% |
| Pulmonary Embolism |
25.0% |
| Thrombocytopenia |
25.0% |
| Urinary Tract Infection |
25.0% |
|
| Secondary |
| Head And Neck Cancer |
54.9% |
| Non-small Cell Lung Cancer |
35.4% |
| Prophylaxis |
5.8% |
| Glioma |
0.6% |
| Lung Neoplasm Malignant |
0.6% |
| Hypertension |
0.5% |
| Colon Cancer |
0.4% |
| Squamous Cell Carcinoma |
0.4% |
| Antidepressant Therapy |
0.3% |
| Antifungal Prophylaxis |
0.3% |
| Pain |
0.2% |
| Renal Cancer |
0.2% |
| Back Pain |
0.1% |
| Constipation |
0.1% |
| Pain In Extremity |
0.1% |
|
| Thrombocytopenia |
10.9% |
| Pulmonary Embolism |
10.1% |
| Sepsis |
6.5% |
| Stomatitis |
5.8% |
| Syncope |
5.8% |
| Visual Acuity Reduced |
5.8% |
| Deep Vein Thrombosis |
5.1% |
| Neutropenia |
5.1% |
| Arteriosclerosis |
4.3% |
| Blood Amylase Increased |
4.3% |
| Hypotension |
4.3% |
| Hypoxia |
4.3% |
| Aortic Thrombosis |
3.6% |
| Pneumonitis |
3.6% |
| Pyrexia |
3.6% |
| Sudden Death |
3.6% |
| Thrombosis |
3.6% |
| Vomiting |
3.6% |
| Acute Respiratory Distress Syndrome |
2.9% |
| Arrhythmia Supraventricular |
2.9% |
|
| Concomitant |
| Hypopharyngeal Cancer |
40.8% |
| Non-small Cell Lung Cancer |
24.5% |
| Product Used For Unknown Indication |
10.2% |
| Rash |
8.2% |
| Brain Neoplasm |
6.1% |
| Convulsion |
2.0% |
| Epilepsy |
2.0% |
| Glioblastoma |
2.0% |
| Neurological Symptom |
2.0% |
| Premedication |
2.0% |
|
| Thrombocytopenia |
42.9% |
| Bone Marrow Failure |
14.3% |
| Septic Shock |
14.3% |
| Aphasia |
7.1% |
| Death |
7.1% |
| Fatigue |
7.1% |
| Pancreatic Enzymes Increased |
7.1% |
|
